semaglutide cardiovascular outcomes study news HUGE NEWS! Contrary to popular belief: GLP-1 weight loss medications are NOT all about aesthetics, they REDUCE risk of death, heart attack, stroke, heart failure, AND ALL CAUSE MORTALITY! Groundbreaking SELECT Semaglutide and Cardiovascular Outcomes in

And the unabsorbed sugars in the gut can also give the faeces a sweet smell

No, restless legs syndrome is not listed as a recognised adverse effect in clinical trial data or MHRA-approved prescribing information for Mounjaro (tirzepatide)

Private sector investments represent approximately 53% of total funding, while government-backed healthcare initiatives contribute 47%, improving accessibility for nearly 52% of patients globally

Case Report The management of our patient included an initial 72-hour fasting plasma glucose test

The last time Novo Nordisk went for centralized drug procurement to get its insulins included in round 6 of Mainland Chinas Value Based Pricing regimen, most long-acting and rapid-acting insulins were given substantial price cuts, impacting the sales of a solid billion-dollar segment in Mainland China

Before making a restart decision, discuss with your provider whether lifestyle factors (stress, sleep, activity) changed since you stopped, or whether your genetic response profile suggests longer-term medication is the right choice for you